OR5BM1P

Across TCGA pan-cancer cohorts, OR5BM1P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated OR5BM1P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR5BM1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5BM1P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, ESCA, and KIRC are the cancer types where OR5BM1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.225	0.729	<.001	54	view →
ESCA	OS	Tertile	III,IV	1.000	0.369	.025	18	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
LGG	DFS	Tertile	All	0.156	0.753	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OR5BM1P–STAD (DFS)

Open the STAD breakdown →